| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 157268 | 2009 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... bmj 372, 2021 | 90711 | 2021 |
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ... Bmj 339, 2009 | 54610 | 2009 |
| Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials JAC Sterne, AJ Sutton, JPA Ioannidis, N Terrin, DR Jones, J Lau, ... Bmj 343, 2011 | 6461 | 2011 |
| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 6186 | 2013 |
| SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ... Bmj 346, 2013 | 5129 | 2013 |
| Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Revista española de cardiología 74 (9), 790-799, 2021 | 2366 | 2021 |
| Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Journal of clinical epidemiology 134, 103-112, 2021 | 2108 | 2021 |
| & Moher, D.(2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... International journal of surgery 88 (105906), 10.1016, 2021 | 1616 | 2021 |
| PRISMA group D Moher, A Liberati, J Tetzlaff, DG Altman Preferred reporting items for systematic reviews and meta-analyses 2009, 151, 2009 | 1215 | 2009 |
| Epidemiology and reporting characteristics of systematic reviews D Moher, J Tetzlaff, AC Tricco, M Sampson, DG Altman PLoS medicine 4 (3), e78, 2007 | 1126 | 2007 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews JP Matthew, EM Joanne, MB Patrick, B Isabelle, CH Tammy, DM Cynthia, ... Bmj 372 (0), 10.1136, 2021 | 920 | 2021 |
| Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study MJ Page, L Shamseer, DG Altman, J Tetzlaff, M Sampson, AC Tricco, ... PLoS medicine 13 (5), e1002028, 2016 | 747 | 2016 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews., 2021, 372, p. n71 MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... DOI: https://doi. org/10.1136/bmj, 0 | 743* | |
| The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis PLoS medicine 6 (7), 1-28, 2009 | 618 | 2009 |
| Academia and clinic annals of internal medicin preferred reporting items for systematic reviews and meta-analyses D Moher, A Liberati, J Tetzlaff, DG Altman Ann. Intern. Med 151, 264-269, 2009 | 570 | 2009 |
| A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... Revista panamericana de salud publica 46, e112, 2023 | 480 | 2023 |
| A., et al.(2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JP Ioannidis PLoS Med 6 (7), e1000100, 2009 | 440 | 2009 |
| PA, Clarke M., Devereaux PJ, Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions … A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gotzsche, J Ioannidis Bmj 339, b2700-b2700, 2009 | 426 | 2009 |
| Hr objartsson MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ... A., Lalu, MM, Li, T., Loder, EW, Mayo-Wilson, E., McDonald, S.,… Moher, D, 1-9, 2021 | 378 | 2021 |
